Showing results (251-260 of 424) with videos related to
Sort By:
Pageof 43
Neuroimage. Clinical|November 22, 2017
Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's DiseaseLeonardo Iaccarino, Gautam Tammewar, Nagehan Ayakta, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2011
AFQ056 treatment of levodopa-induced dyskinesias: results of 2 randomized controlled trialsDaniela Berg, Jana Godau, Claudia Trenkwalder, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2017
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaGünter U Höglinger, Gesine Respondek, Maria Stamelou, et al.Nature Medicine|August 13, 2021
Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trialTien Dam, Adam L Boxer, Lawrence I Golbe, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 22, 2010
Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS familyAdam L Boxer, Ian R Mackenzie, Bradley F Boeve, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 5, 2021
Uniform data set language measures for bvFTD and PPA diagnosis and monitoringAdam M Staffaroni, Sandra Weintraub, Katya Rascovsky, et al.Alzheimer'S Research & Therapy|August 29, 2024
Clinical implications of head trauma in frontotemporal dementia and primary progressive aphasiaBreton M Asken, Jessica M Bove, Russell M Bauer, et al.Alzheimer'S Research & Therapy|September 22, 2023
Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairmentNidhi S Mundada, Julio C Rojas, Lawren Vandevrede, et al.Journal of Alzheimer'S Disease : JAD|September 28, 2020
Plasma Glial Fibrillary Acidic Protein Levels Differ Along the Spectra of Amyloid Burden and Clinical Disease StageBreton M Asken, Fanny M Elahi, Renaud La Joie, et al.JAMA Neurology|April 26, 2016
Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal DegenerationMiguel A Santos-Santos, Maria Luisa Mandelli, Richard J Binney, et al.Pageof 43